Neuropeptide Y (22-36) tinostat Smiles: C[C@@]1(O)[C@@H](O)[C@H](C)CC=CC=C[C@H](CC)[C@H](O)C[C@@H]2O[C@]3(CC[C@H](C)[C@H](C[C@@H](C)O)O3)[C@@H](C)[C@H](OC(=O)C=C[C@H](C)[C@@H](O)[C@H](C)C(=O)[C@H](C)[C@@H](O)[C@H](C)C1=O)[C@@H]2C |t:8

Smiles: C[C@@]1(O)[C@@H](O)[C@H](C)CC=CC=C[C@H](CC)[C@H](O)C[C@@H]2O[C@]3(CC[C@H](C)[C@H](C[C@@H](C)O)O3)[C@@H](C)[C@H](OC(=O)C=C[C@H](C)[C@@H](O)[C@H](C)C(=O)[C@H](C)[C@@H](O)[C@H](C)C1=O)[C@@H]2C |t:8

83 mg/mL (134

the beta-nitrostyrene derivative

2-Keto Crizotinib (PF-06260182) is active and considerably less potent than crizotinib

Smiles: CC1=NC(CCC(=O)NCCOC2C=CC(=CC=2)OCC(=O)N[C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)NCC2C=CC(=CC=2)C2SC=NC=2C)C(C)(C)C)=CC=C1C1=CN=C(NCC2=C(F)C=CC3OCCC2=3)N2C=NN=C21

Neuropeptide Y (22-36) tinostat Smiles: C[C@@]1(O)[C@@H](O)[C@H](C)CC=CC=C[C@H](CC)[C@H](O)C[C@@H]2O[C@]3(CC[C@H](C)[C@H](C[C@@H](C)O)O3)[C@@H](C)[C@H](OC(=O)C=C[C@H](C)[C@@H](O)[C@H](C)C(=O)[C@H](C)[C@@H](O)[C@H](C)C1=O)[C@@H]2C |t:8Neuropeptide Y (22 36), a 15 amino acid peptide, is a fragment of Neuropeptide Y. Neuropeptide Y (22 36) acts on Y2 receptor and retains subnanomolar affinity for the Y2 receptor. Product information CAS Number: 119019 65 7 Molecular Weight: 1903. 19 Formula: C85H139N29O21 Chemical Name: (2S) 2 [(2S) 2 [(2S,3R) 2 [(2S,3S) 2 [(2S) 2 [(2S) 2 [(2S,3S) 2 [(2S) 2 [(2S) 2 [(2S) 2 [(2S) 2 [(2S) 2 [(2S) 2 amino 3 hydroxypropanamido]propanamido] 4